Tamburrini, Enrica
 Distribuzione geografica
Continente #
NA - Nord America 3.041
EU - Europa 2.957
AS - Asia 1.075
AF - Africa 56
OC - Oceania 26
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 7.182
Nazione #
US - Stati Uniti d'America 2.970
DE - Germania 641
SE - Svezia 567
IT - Italia 551
CN - Cina 365
SG - Singapore 335
FR - Francia 296
UA - Ucraina 254
IE - Irlanda 190
GB - Regno Unito 126
ID - Indonesia 109
FI - Finlandia 98
IN - India 72
RU - Federazione Russa 60
CA - Canada 57
PL - Polonia 56
TR - Turchia 40
AU - Australia 25
BE - Belgio 23
IR - Iran 23
NL - Olanda 23
HK - Hong Kong 19
SA - Arabia Saudita 19
CI - Costa d'Avorio 17
AT - Austria 13
PH - Filippine 13
PK - Pakistan 12
RO - Romania 11
MX - Messico 10
MY - Malesia 10
BR - Brasile 9
CH - Svizzera 9
EG - Egitto 9
ES - Italia 9
EU - Europa 7
JP - Giappone 7
PE - Perù 7
IL - Israele 6
TN - Tunisia 6
VN - Vietnam 6
ZA - Sudafrica 6
BD - Bangladesh 5
CZ - Repubblica Ceca 5
GR - Grecia 5
MA - Marocco 5
KR - Corea 4
LT - Lituania 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
JO - Giordania 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
SD - Sudan 3
TH - Thailandia 3
CM - Camerun 2
CO - Colombia 2
DK - Danimarca 2
IQ - Iraq 2
KE - Kenya 2
LK - Sri Lanka 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CY - Cipro 1
GE - Georgia 1
GL - Groenlandia 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 7.182
Città #
Chandler 719
Ashburn 259
Singapore 254
Dublin 186
Jacksonville 159
San Mateo 149
New York 128
Jakarta 109
Milan 109
Rome 108
Ann Arbor 84
Nanjing 84
Wilmington 80
Dearborn 71
Boston 54
Kraków 53
Moscow 50
Woodbridge 49
Princeton 47
Marseille 44
Lawrence 43
Helsinki 42
Cattolica 40
Chicago 36
Boardman 34
Izmir 34
Beijing 32
Houston 32
Lancaster 30
Munich 29
Redwood City 29
Bremen 28
Seattle 28
Nürnberg 27
Los Angeles 24
Nanchang 24
Norwalk 22
Ottawa 20
Augusta 19
Brussels 19
Fairfield 18
Mountain View 18
Abidjan 17
University Park 16
Hebei 15
London 15
Toronto 15
Jiaxing 14
Guangzhou 13
Pune 13
Shenyang 13
Tianjin 13
Amsterdam 12
Fremont 12
Hangzhou 12
Hong Kong 12
Washington 12
Dammam 11
Vienna 11
Zhengzhou 11
Kish 10
Leawood 10
Oggiono 10
Andover 9
Cuauhtémoc 9
Jinan 9
Kunming 9
San Giovanni Bianco 9
Zurich 9
Changsha 8
Falls Church 8
Sydney 8
Verona 8
Al Qatif 7
Hefei 7
Richmond 7
Detroit 6
Paris 6
Timisoara 6
Turin 6
Frankfurt am Main 5
Lahore 5
Lima 5
Melbourne 5
Monza 5
Sacramento 5
Santa Clara 5
St Louis 5
Swansea 5
Boydton 4
Brno 4
Busto Arsizio 4
Cairo 4
Cape Town 4
Carate Brianza 4
Castelfranco Emilia 4
Edinburgh 4
Florence 4
Indiana 4
Madrid 4
Totale 3.911
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 431
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 210
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 139
Excretion of SARS-CoV-2 in human breast milk 132
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 124
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 122
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 120
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 109
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 109
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 108
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Migranti cinesi in gravidanza: stato sierologico relativo alle principali malattie infettive ed accesso ai servizi sanitari. L’esperienza nelle comunità di Roma e Prato 107
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 105
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 105
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 102
Cognitive reserve and neuropsychological functioning in older HIV-infected people 101
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 98
Oral lesions in HIV and HCV co-infected individuals in HAART era 97
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 97
Rubella susceptibility profile in pregnant women with HIV 95
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 95
Delivery Management in Maternal Varicella Peripartum Infection with Vulvar Lesions: A Case Report 93
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 92
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 86
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 85
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario 84
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 82
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 82
Oral lesions in HIV and HCV co-infected individuals in HAART era 79
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 79
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 79
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 77
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 76
Sarilumab use in severe SARS-CoV-2 pneumonia 76
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. 75
Dental care and HIV-infected individuals: are they equally treated? 73
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 72
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 72
Residual respiratory impairment after COVID-19 pneumonia 71
Rubella susceptibility profile in pregnant women with HIV 70
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 70
Glucose plasma levels and pregnancy outcomes in women with HIV 69
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: A multicentre case series 67
Pregnancy outcomes in women with advanced HIV infection in Italy 65
Enhancement of vaccination attitude and flu vaccination coverage among pregnant women attending birthing preparation course 65
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 65
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 64
Antiretroviral treatment in pregnancy: a six-years perspective on recent trands in prescription patterns, viral load suppression, and pregnancy outcomes. 63
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens 63
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 63
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy 63
Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women 63
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001-2011 61
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 61
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 60
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 60
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 60
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine 59
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 58
Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy 57
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 57
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 57
HCV–HIV coinfected pregnant women: data from a multicentre study in Italy 56
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 55
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy 54
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 54
Residual respiratory impairment after COVID-19 pneumonia 53
In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers 53
People Living with HIV in the COVID-19 Era: A Case Report 52
Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2 52
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV 52
Glucose plasma levels and pregnancy outcomes in women with HIV 51
Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero 50
Pregnancy outcomes in women with advanced HIV infection in Italy 49
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 49
Risk factors for bloodstream infections in gynecological cancer 49
HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy 47
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 46
Pregnancy outcomes in HIV-infected women of advanced maternal age 45
Off-label use of tocilizumab in patients with SARS-CoV-2 infection 45
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients? 44
Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study 43
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT 43
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life 42
Women Facing HIV. Key Question on Women with HIV Infection: Italian Consensus Workshop 41
Body mass index and weight gain in pregnant women with HIV: a national study in Italy 41
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1 41
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 39
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report 37
People Living with HIV in the COVID-19 Era: A Case Report 37
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT 37
Declining HCV seroprevalence in pregnant women with HIV 36
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 36
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women 33
COVID-19 diagnosis does not rule out other concomitant diseases 33
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 27
Antibodies anti-HIV and immunologic status in newborns from i.v. drug addicted mothers 26
Is smallpox vaccination protective against human monkeypox? 22
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 19
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 15
Totale 7.191
Categoria #
all - tutte 34.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020395 0 0 0 0 47 82 31 33 34 44 64 60
2020/2021620 25 64 10 61 73 36 70 16 95 44 108 18
2021/2022910 102 63 21 63 34 22 35 159 37 58 129 187
2022/20232.343 245 273 207 392 233 301 100 172 247 70 77 26
2023/20241.166 44 288 39 72 59 195 74 33 35 56 114 157
2024/2025555 36 57 218 73 171 0 0 0 0 0 0 0
Totale 7.305